✦ LIBER ✦

A Phase II Trial of Topotecan in Patients with Advanced, Persistent, or Recurrent Endometrial Carcinoma: A Gynecologic Oncology Group Study

✍ Scribed by David Scott Miller; John A. Blessing; Samuel S. Lentz; Steven E. Waggoner

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Phase II Trial of Anastrozole in Advan

✍ Peter G. Rose; Virginia L. Brunetto; Linda VanLe; Jeffrey Bell; Joan L. Walker; 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Phase II Trial of Pyrazoloacridine in Pa

✍ Steven C. Plaxe; John A. Blessing; Nader Husseinzadeh; Kenneth D. Webster; Janet 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 39 KB

Phase II trial of danazol in advanced, r

✍ Allan Covens; Virginia L Brunetto; Maurie Markman; James W Orr Jr.; Samuel S Len 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 72 KB

Phase II trial of cisplatin as first-lin

✍ Jt Thigpen; JA Blessing; H Homesley; WT Creasman; G Sutton 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 136 KB

Phase II trial of clsplatin as first-lin

✍ J.Tate Thigpen; John A. Blessing; Howard Homesley; William T. Creasman; Gregory 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 331 KB

Phase II trial of trastuzumab in women w

✍ Gini F. Fleming; Michael W. Sill; Kathleen M. Darcy; D. Scott McMeekin; J. Tate 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 477 KB